Filing Details

Accession Number:
0001093557-21-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-06 17:10:58
Reporting Period:
2021-01-04
Accepted Time:
2021-01-06 17:10:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1093557 Dexcom Inc DXCM Surgical & Medical Instruments & Apparatus (3841) 330857544
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1466545 Richard Doubleday 6340 Sequence Drive
San Diego CA 92121
Evp Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-12-29 950 $0.00 32,549 No 5 G Direct
Common Stock Disposition 2021-01-04 27 $362.96 32,522 No 4 S Direct
Common Stock Disposition 2021-01-04 28 $365.16 32,494 No 4 S Direct
Common Stock Disposition 2021-01-04 10,970 $366.07 21,524 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 9,983 Indirect by Trust
Footnotes
  1. The transaction represents a gift by the Reporting Person of 950 shares to a charitable donor advised fund.
  2. Included in this number are 3,916 unvested restricted stock units that will be forfeited to the Company on April 1, 2021 in accordance with Mr. Doubleday's Transition & Consulting Agreement.
  3. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
  4. This transaction was executed in multiple trades at prices ranging from $362.84 to $363.0623. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
  5. This transaction was executed in multiple trades at prices ranging from $365.0432 to $365.1871. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
  6. Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee.